|
371 |
Nahrungsergänzungsmittel: Fluch oder Segen?
Enthalten in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz Bd. 60, 20.2.2017, Nr. 3, date:3.2017: 257-259
|
|
|
|
372 |
Neurologist visit has short-term impact on headache costs
Enthalten in PharmacoEconomics & outcomes news Bd. 795, 27.1.2018, Nr. 1, date:1.2018: 22
|
|
|
|
373 |
New Era for Schools and Programs of Public Health in Canada
Enthalten in Public health reviews Bd. 33, 12.4.2017, Nr. 1, date:6.2011: 277-288
|
|
|
|
374 |
New listings on the Australian PBS
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 33
|
|
|
|
375 |
New NICE guidance recommends Extavia for MS patients
Enthalten in PharmacoEconomics & outcomes news Bd. 794, 13.1.2018, Nr. 1, date:1.2018: 37
|
|
|
|
376 |
NHS: new CDF means faster access to innovative treatments
Enthalten in PharmacoEconomics & outcomes news Bd. 796, 10.2.2018, Nr. 1, date:2.2018: 34
|
|
|
|
377 |
NICE issues draft policy on managing conflicts of interest
Enthalten in PharmacoEconomics & outcomes news Bd. 783, 29.7.2017, Nr. 1, date:7.2017: 7
|
|
|
|
378 |
NICE issues new guidance for asthma
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 35
|
|
|
|
379 |
NICE launches new health-check service for economic models
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 2
|
|
|
|
380 |
NICE recommends gene therapy for 'bubble baby syndrome'
Enthalten in PharmacoEconomics & outcomes news Bd. 794, 13.1.2018, Nr. 1, date:1.2018: 38
|
|
Administration
